Overall, these results demonstrated that miR-27a-3p binds to TET1 and downregulates TET1 to activate EMT by promoting DNA methylation of ADCY6, thus promoting proliferation, migration and invasion of breast cancer cells (Figure 9E). Here, TET1 is linked to breast carcinoma.